Clinical trial
Vaccine to Prevent West Nile Virus Disease
NCT00106769 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00106769 |
|---|---|
| Title | Vaccine to Prevent West Nile Virus Disease |
| Official title | A Phase I Study of the Safety and Immunogenicity of a West Nile Virus Recombinant DNA Plasmid Vaccine, VRC-WNVDNA017-00 VP, in Healthy Adult Volunteers |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy, West Nile Fever, Healthy Volunteer, HV |
| Intervention type | Drug |
| Interventions | VRC-WNVDNA017-00-VP |
| Enrollment | 15 |
| Start date | Mar 22, 2005 |
| Completion | Jan 15, 2008 |
| First posted | Mar 30, 2005 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: